Hepatitis C virus: The viral way to fatty liver

Journal of Hepatology

Volumn 46, Issue 6, 2007, Pages 985-987

  Clément, Sophie ^a   Negro, Francesco ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

DISEASE ASSOCIATION; EDITORIAL; FATTY ACID OXIDATION; FATTY LIVER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL;

ANIMALS; FATTY LIVER; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HEPACIVIRUS; HUMANS; LIPID METABOLISM; LIPOPROTEINS, VLDL; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS;

EID: 34247636126     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.03.005     Document Type: Editorial

References (33)

1. Asselah T., Rubbia-Brandt L., Marcellin P., and Negro F. Steatosis in chronic hepatitis C: why does it really matter?. Gut 55 (2006) 123-130
2. Czaja A.J., Carpenter H.A., Santrach P.J., and Moore S.B. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29 (1998) 198-206
3. Thomopoulos K.C., Arvaniti V., Tsamantas A.C., Dimitropoulou D., Gogos C.A., Siagris D., et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol 18 (2006) 233-237
4. Mihm S., Fayyazi A., Hartmann H., and Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25 (1997) 735-739
5. Rubbia-Brandt L., Quadri R., Abid K., Giostra E., Male P.J., Mentha G., et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33 (2000) 106-115
6. Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.F., Utili R., and Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33 (2001) 1358-1364
7. Castera L., Hezode C., Roudot-Thoraval F., Lonjon I., Zafrani E.S., Pawlotsky J.M., et al. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis. Gut 53 (2004) 420-424
8. Kumar D., Farrell G.C., Fung C., and George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes. Genotype-specific reversal of hepatic steatosis after sustained response to antiviral therapy. Hepatology 36 (2002) 1266-1272
9. Poynard T., Ratziu V., McHutchison J., Manns M., Goodman Z., Zeuzem S., et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 38 (2003) 75-85
10. Rubbia-Brandt L., Giostra E., Mentha G., Quadri R., and Negro F. Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon. J Hepatol 35 (2001) 307
11. Serfaty L., Andreani T., Giral P., Carbonell N., Chazouillères O., and Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 34 (2001) 428-434
12. Hofer H., Bankl H.C., Wrba F., Steindl-Munda P., Peck-Radosavljevic M., Osterreicher C., et al. Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterol 97 (2002) 2880-2885
13. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94 (1997) 1200-1205
14. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78 (1997) 1527-1531
15. Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chretien Y., et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 16 (2002) 185-194
16. Abid K., Pazienza V., De Gottardi A., Rubbia-Brandt L., Conne B., Pugnale P., et al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol 42 (2005) 744-751
17. Mirandola S., Realdon S., Iqbal J., Gerotto M., Dal Pero F., Bortoletto G., et al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 130 (2006) 1661-1669
18. Yamaguchi A., Tazuma S., Nishioka T., Ohoshi W., Hyogo H., Nomura S., et al. Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci 50 (2005) 1361-1371
19. Cheng Y., Dharancy S., Malapel M., and Desreumaux P. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A. World J Gastroenterol 11 (2005) 7591-7596
20. Dharancy S., Malapel M., Perlemuter G., Roskams T., Cheng Y., Dubuquoy L., et al. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 128 (2005) 334-342
21. De Gottardi A., Pazienza V., Pugnale P., Bruttin F., Rubbia-Brandt L., Juge-Aubry C.E., et al. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection. Aliment Pharmacol Ther 23 (2006) 107-114
22. Su A.I., Pezacki J.P., Wodicka L., Brideau A.D., Supekova L., Thimme R., et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99 (2002) 15669-15673
23. Tsutsumi T., Suzuki T., Shimoike T., Suzuki R., Moriya K., Shintani Y., et al. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology 35 (2002) 937-946
24. Jackel-Cram C., Babiuk L.A., and Liu Q. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: Genotype-3a core has stronger effect than genotype-1b core. J Hepatol 46 (2007) 999-1008
25. Bergqvist A., and Rice C.M. Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol 75 (2001) 772-781
26. Moorman J.P., Prayther D., McVay D., Hahn Y.S., and Hahn C.S. The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization. Virology 312 (2003) 320-329
27. Yamanaka T., Kodama T., and Doi T. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem Biophys Res Commun 294 (2002) 528-534
28. Yamanaka T., Uchida M., and Doi T. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem Biophys Res Commun 294 (2002) 521-527
29. Hope R.G., and McLauchlan J. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J Gen Virol 81 (2000) 1913-1925
30. Hope R.G., Murphy D.J., and McLauchlan J. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J Biol Chem 277 (2002) 4261-4270
31. McLauchlan J., Lemberg M.K., Hope G., and Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 21 (2002) 3980-3988
32. Jhaveri R., McHutchison J.G., Patel K., and Diehl A.M. The role of hepatitis C genotype 3 core protein domain 3 in intrahepatic steatosis. Hepatology 44 (2006) 300A
33. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., et al. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76 (2002) 4008-4021